Deutsch English Français

Contact

EP2301576

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2301576

EP2301576 - Therapeutic use of Anti-CS1 Antibodies [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 26.07.2013 Database last updated on 24.04.2024
Most recent event Tooltip	24.01.2014	Change - lapse in a contracting state State(s) deleted from list of lapses: CY	published on 26.02.2014 [2014/09]
Applicant(s)	For all designated states AbbVie Biotherapeutics Inc. 1500 Seaport Boulevard Redwood City, CA 94063 / US
	[2013/12]
Former [2012/38]	For all designated states Abbott Biotherapeutics Corp. 1500 Seaport Boulevard Redwood City, CA 94063 / US
Former [2011/13]	For all designated states Abbott Biotherapeutics Corp. 1500 Seaport Boulevard Redwood City CA 94063 / US
Inventor(s)	01 / Williams, Marna 347 Ely Place Palo Alto, CA 94306 / US
	02 / Tso, J. Yun 445 Oak Grove Avenue, no. 16 Menlo Park, CA 94025 / US
	03 / Landolfi, Nicolas F. 240 Gloria Circle Palo Alto, CA 94025 / US
	04 / Liu, Gao 1135 Phyllis Avenue Mountain View, CA 94040 / US
	[2011/45]
Former [2011/13]	01 / Williams, Marna 347 Ely Place Palo Alto, CA 94306 / US
	02 / Tso, J. Jun 445 Oak Grove Avenue 16 Menlo Park, CA 94025 / US
	03 / Landolfi, Nicolas F. 240 Gloria Circle Palo Alto, CA 94025 / US
	04 / Liu, Gao 1135 Phyllis Avenue Mountain View, CA 94040 / US
Representative(s)	Wilkinson, Marc George, et al Avidity IP Broers Building Hauser Forum 21 JJ Thomson Ave Cambridge CB3 0FA / GB
	[N/P]
Former [2013/15]	Wilkinson, Marc George, et al Avidity IP Kestrel House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB
Former [2012/38]	Broughton, Jon Philip avidity IP Merlin House Falconry Court Baker's Lane, Epping Essex CM16 5DQ / GB
Former [2011/13]	Broughton, Jon Philip HLBBshaw Merlin House Falconry Court Baker's Lane Epping Essex CM16 5DQ / GB
Application number, filing date	10180748.5	08.11.2004
	[2011/13]
Priority number, date	US20040557621P	29.03.2004 Original published format: US 557621 P
	US20040557620P	29.03.2004 Original published format: US 557620 P
	US20040557622P	29.03.2004 Original published format: US 557622 P
	US20040842011	07.05.2004 Original published format: US 842011
	US20040982357	05.11.2004 Original published format: US 982357
	[2011/13]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2301576
	Date:	30.03.2011
	Language:	EN
	[2011/13]
	Type:	B1 Patent specification
	No.:	EP2301576
	Date:	19.09.2012
	Language:	EN
	[2012/38]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	23.02.2011
Classification	IPC:	A61K39/395, C07K16/28, A61P35/00, A61P37/00, C12N5/20	[2011/13]
	CPC:	C07K16/2803 (EP,US); A61K39/395 (KR); A61P35/00 (EP); A61P37/00 (EP); C07K14/70503 (EP,US); C07K16/2806 (EP,US); (+) A61K2039/505 (EP,US); C07K2317/24 (EP,US); C07K2317/41 (EP,US); C07K2317/56 (EP,US); C07K2317/565 (EP,US); C07K2317/73 (EP,US); C07K2317/732 (EP,US); C07K2317/76 (EP,US); C07K2317/92 (EP,US); C07K2319/00 (EP,US); C07K2319/30 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2011/13]
Extension states	AL	08.10.2010
	HR	08.10.2010
	LT	08.10.2010
	LV	08.10.2010
	MK	08.10.2010
	YU	08.10.2010
Title	German:	Therapeutische Verwendung von Anti-CS1-Antikörpern	[2011/13]
	English:	Therapeutic use of Anti-CS1 Antibodies	[2011/13]
	French:	Utilisation thérapeutique d'anticorps anti-CS1	[2011/13]
Examination procedure	08.10.2010	Examination requested [2011/13]
	29.09.2011	Amendment by applicant (claims and/or description)
	09.03.2012	Communication of intention to grant the patent
	18.07.2012	Fee for grant paid
	18.07.2012	Fee for publishing/printing paid
Parent application(s) Tooltip	EP04810631.4 / EP1729803
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040810631) is 25.09.2007
Opposition(s)	20.06.2013	No opposition filed within time limit [2013/35]
Fees paid	Renewal fee
	08.10.2010	Renewal fee patent year 03
	08.10.2010	Renewal fee patent year 04
	08.10.2010	Renewal fee patent year 05
	08.10.2010	Renewal fee patent year 06
	24.11.2010	Renewal fee patent year 07
	23.11.2011	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	deleted
	[2014/09]
Former [2013/52]	CY	19.09.2012
Documents cited:	Search	[IA]WO0146260 (BRISTOL MYERS SQUIBB CO [US], et al) [I] 1,13 * page 54, lines 1-31; example 5 * [A] 2-12,14-24;
		[A]WO0222660 (HYSEQ INC [US], et al) [A] 1-24 * claims 20,28; sequence 741 *;
		[IA]US2003113332 (MATHEW PORUNELLOR A [US], et al) [I] 1,13 * figure 7; example 2; claims 23,36 * [A] 2-12,14-24;
		[A] - BOUCHON A ET AL, "CUTTING EDGE:ACTIVATION OF NK CELL-MEDIATED CYTOTOXICITY BY A SAP-INDEPENDENT RECEPTOR OF THE CD2 FAMILY", JOURNAL OF IMMUNOLOGY, WILLIAMS & WILKINS CO, US, (2001), vol. 167, ISSN 0022-1767, pages 5517 - 5521, XP008072681 [A] 1-24 * page 5517, column RIGHT, paragraphs 2,4 * * page 5519, column LEFT, paragraph 1 - paragraph 2 *
		[T] - RICE ET AL, "Eradication of Tumors in Pre-Clinical Models of Multiple Myeloma by Anti-CS1 Monoclonal Antibody HuLuc63: Mechanism of Action Studies.", BLOOD, ASH ANNUAL MEETING ABSTRACTS 2006, vol. 8, no. 11, (200611), page 1, URL: http://www.abstracts2view.com/hem4806/view.php?nu=HEM06L1_1177, (20070420), XP002430427 [T] 1-24 * abstract *
		[T] - HSI ET AL, "CS1: A Potential New Therapeutic Target for the Treatment of Multiple Myeloma.", BLOOD, ASH ANNUAL MEETING ABSTRACTS 2006, vol. 108, no. 11, (20061116), page 1, URL: http://www.abstracts2view.com/hem4806/view.php?nu=HEM06L1_954&terms=, (20070419), XP002430428 [T] 1-20 * abstract * DOI: http://dx.doi.org/10.1182/blood-2006-04-016253
		[A] - MURPHY JOHN J ET AL, "Studies on a novel human immunoglobulin superfamily member (19A) with structural similarity to CD2", IMMUNOLOGY, & ANNUAL CONGRESS OF THE BRITISH SOCIETY FOR IMMUNOLOGY; HARROGATE, UK; DECEMBER 05-08, 2000, (200012), vol. 101, no. Supplement 1, ISSN 0019-2805, page 89, XP008078069 [A] 1-24 * abstract *
	by applicant	US4179337
		US4301144
		US4469863
		US4496689
		US4634664
		US4634666
		US4640835
		US4670417
		WO8705330
		US4791192
		US4946778
		US5004692
		US5034506
		WO9110741
		WO9117271
		WO9201047
		US5216141
		WO9312227
		US5235033
		US5386023
		US5445934
		WO9525116
		WO9535505
		US5530101
		US5545806
		US5585089
		US5602240
		US5637684
		US5644048
		US5677427
		US5693761
		US5693762
		US5700637
		US5969108
		US6120767
		WO0055627
		US6150584
		US6180370
		US6329508
		WO0200729
		US2003113332
		WO2004029207
		US6737056
		US2004132101
		- NI, J. ET AL., "Immunological abnormality in C3H/HeJ mice with heritable inflammatory bowel disease", CELL IMMUNOL., (1996), vol. 169, pages 7 - 15
		- OGURA, Y. ET AL., "A frameshift mutation in NOD2 associated with susceptibility to Crohn's Disease", NATURE, (2001), vol. 411, pages 603 - 606
		- RUIZ-ARUGELLES GJ; SAN MIGUEL JF, "Cell Surface Markers in Multiple Myeloma", MAYO CLIN. PROC., (1994), vol. 69, pages 684 - 90
		- LEO R ET AL., "Multiparameter analysis of normal and malignant human plasma cells", ANN. HEMATOL., (1992), vol. 64, pages 132 - 9
		- TRICOT G ET AL., "Poor prognosis in Multiple Myeloma", BLOOD, (1995), vol. 86, pages 4250 - 2
		- BOLES; MATHEW, IMMUNOGENETICS, (2001), vol. 52, pages 302 - 307
		- BOUCHON ET AL., J. IMMUNOL., (2001), vol. 167, pages 5517 - 5521
		- MURPHY ET AL., BIOCHEM. J., (2002), vol. 361, pages 431 - 436
		- IMMUNOGENETICS, (2001), vol. 52, pages 302 - 307
		- BOUCHON, A. ET AL., J. OF IMMUNO., (2001), pages 5517 - 5521
		- MURPHY, J. ET AL., BIOCHEM. J., (2002), vol. 361, pages 431 - 436
		- SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, pages 482 - 489
		- NEEDLEMAN; WUNSCH, J. MOL. BIOL., (1970), vol. 48, pages 443 - 453
		- PEARSON; LIPMAN, PROC. NAT'1. ACAD. SCI. USA, (1988), vol. 85, pages 2444 - 2448
		- ALTSCHUL ET AL., NUC. ACIDS RES., (1977), vol. 25, pages 3389 - 3402
		- ALTSCHUL ET AL., J. MOL. BIOL., (1990), vol. 215, pages 403 - 410
		- HENIKOFF; HENIKOFF, PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 10915 - 919
		- KARLIN; ALTSCHUL, PROC. NAT'1. ACAD. SCI. USA, (1993), vol. 90, pages 5873 - 5787
		- BEAUCAGE ET AL., TETRAHEDRON, (1993), vol. 49, pages 1925 - 1963
		- LETSINGER, J. ORG. CHEM., (1970), vol. 35, pages 3800 - 3803
	- SPRINZL ET AL., EUR. J. BIOCHEM., (1977), vol. 81, pages 579 - 589
	- LETSINGER ET AL., NUCL. ACIDS RES., (1986), vol. 14, pages 3487 - 499
	- SAWAI ET AL., CHEM. LETT., (1984), page 805
	- LETSINGER ET AL., J. AM. CHEM. SOC., (1988), vol. 110, pages 4470 - 4471
	- PAUWELS ET AL., CHEMICA SCRIPTA, (1986), vol. 26, pages 141 - 149
	- MAG ET AL., NUCLEIC ACIDS RES., (1991), vol. 19, pages 1437 - 441
	- BRILL ET AL., J. AM. CHEM. SOC., (1989), vol. 111, pages 2321 - 2322
	- EGHOLM, J. AM. CHEM. SOC., (1992), vol. 114, pages 1895 - 1897
	- MEIER ET AL., CHEM. INT. ED. ENGL., (1992), vol. 31, pages 1008 - 1010
	- NIELSEN, NATURE, (1993), vol. 365, pages 566 - 568
	- CARLSSON ET AL., NATURE, (1996), vol. 380, page 207
	- DENPCY ET AL., PROC. NATL. ACAD. SCI. USA, (1995), vol. 92, pages 6097 - 101
	- KIEDROWSKI ET AL., ANGEW. CHEM. INTL. ED. ENGLISH, (1991), vol. 30, pages 423 - 426
	- LETSINGER ET AL., NUCLEOSIDE AND NUCLEOTIDE, (1994), vol. 13, page 1597
	- MESMAEKER ET AL., BIOORGANIC AND MEDICINAL CHEM. LETT., (1994), vol. 4, pages 395 - 398
	- JEFFS ET AL., J. BIOMOLECULAR NMR, (1994), vol. 34, page 17
	- HORN ET AL., TETRAHEDRON LETT., (1996), vol. 37, page 743
	- JENKINS ET AL., CHEM. SOC. REV., (1995), pages 169 - 176
	- C&E NEWS, (19970602), page 35
	- HUNTER ET AL., NATURE, (1962), vol. 144, page 945
	- DAVID ET AL., BIOCHEMISTRY, (1974), vol. 13, pages 1014 - 1021
	- PAIN ET AL., J. IMMUNOL. METH., (1981), vol. 40, pages 219 - 230
	- NYGREN, J. HISTOCHEM. AND CYTOCHEM, (1982), vol. 30, pages 407 - 412
	- "Overview of principles of hybridization and the strategy of nucleic acid assays", TIJSSEN, Hybridization with Nucleic Probes, ELSEVIER, (1993), vol. 24
	- FRESHNEY, Culture of Animal Cells a Manual of Basic Technique(2d ed.), WILEY-LISS, (1994), pages 231 - 241
	- LANZAVECCHIA ET AL., EUR. J. IMMUNOL., (1987), vol. 17, page 105
	- HUSTON ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1988), vol. 85, pages 5879 - 5883
	- BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
	- HUNKAPILLER; HOOD, NATURE, (1986), vol. 323, pages 15 - 16
	- MCCAFFERTY ET AL., NATURE, (1990), vol. 348, pages 552 - 554
	- KOHLER; MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497
	- KOZBOR ET AL., IMMUNOLOGY TODAY, (1983), vol. 4, page 72
	- MARKS ET AL., BIOTECHNOLOGY, (1992), vol. 10, pages 779 - 783
	- BATEMAN A. ET AL., NUCLEIC ACIDS RES., (1999), vol. 27, pages 260 - 2
	- CARTER ET AL., NUCL. ACIDS RES., (1986), vol. 13, page 4331
	- OESTBERG ET AL., HYBRIDOMA, (1983), vol. 2, pages 361 - 367
	- HUSE ET AL., SCIENCE, (1989), vol. 246, pages 1275 - 1281
	- COIA G ET AL., J. IMMUNOL. METHODS 1, (2001), vol. 254, no. 1-2, pages 191 - 7
	- HANES J. ET AL., NAT. BIOTECHNOL., (2000), vol. 18, no. 12, pages 1287 - 92
	- PROC. NATL. ACAD. SCI. U. S. A., (1998), vol. 95, no. 24, pages 14130 - 5
	- PROC. NATL. ACAD. SCI. U. S. A., (1997), vol. 94, no. 10, pages 4937 - 42
	- YEUNG ET AL., BIOTECHNOL. PROG., (2002), vol. 18, no. 2, pages 212 - 20
	- BOEDER, E. T. ET AL., NAT. BIOTECHNOL., (1997), vol. 15, no. 6, pages 553 - 7
	- BYERS, B. S. ET AL., SEMINARS CELL BIOL, (1991), vol. 2, pages 59 - 70
	- FANGER, M. W. ET AL., IMMUNOL TODAY, (1991), vol. 12, pages 51 - 54
	- LEFKOVITS AND PERNIS,, Immunological Methods, ACADEMIC PRESS, (1979), vol. I, II
	- 1994, PIERCE CHEMICAL COMPANY CATALOG, TECHNICAL SECTION ON CROSS-LINKERS, (1994), pages 155 - 200
	- WU; WALLACE, GENOMICS, (1989), vol. 4, pages 560 - 569
	- LANDEGREN ET AL., SCIENCE, (1988), vol. 241, pages 1077 - 1080
	- BARRINGER ET AL., GENE, (1990), vol. 89, pages 117 - 122
	- KWOH ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 1173 - 1177
	- GUATELLI ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 1874 - 1878
	- KITAMURA ET AL., PROC. NAT'L ACAD. SCI. USA, (1995), vol. 92, pages 9146 - 9150
	- CREIGHTON, Proteins: Structure and Molecular Properties, FREEMAN, (1992), pages 79 - 86
	- APLIN; WRISTON, CRC CRIT. REV. BIOCHEM, (1981), pages 259 - 306
	- SOJAR; BAHL, ARCH. BIOCHEM. BIOPHYS., (1987), vol. 259, pages 52 - 57
	- EDGE ET AL., ANAL. BIOCHEM., (1981), vol. 118, pages 131 - 137
	- THOTAKURA ET AL., METH. ENZYMOL., (1987), vol. 138, pages 350 - 359
	- FIELD ET AL., MOL. CELL. BIOL., (1988), vol. 8, pages 2159 - 2165
	- EVAN ET AL., MOLECULAR AND CELLULAR BIOLOGY, (1985), vol. 5, pages 3610 - 3616
	- PABORSKY ET AL., PROTEIN ENGINEERING, (1990), vol. 3, no. 6, pages 547 - 553
	- HOPP ET AL., BIOTECHNOLOGY, (1988), vol. 6, pages 1204 - 1210
	- MARTIN ET AL., SCIENCE, (1992), vol. 255, pages 192 - 194
	- SKINNER ET AL., J. BIOL. CHEM., (1991), vol. 266, pages 15163 - 15166
	- LUTZ-FREYERMUTH ET AL., PROC. NATL. ACAD. SCI. USA, (1990), vol. 87, pages 6393 - 6397
	- KOHLER; MILSTEIN, NATURE, (1975), vol. 256, page 495
	- GODING, Monoclonal Antibodies: Principles and Practice, ACADEMIC PRESS, (1986), pages 59 - 103
	- SHIELDS, R.L. ET AL., J. BIOL. CHEM., (2002), vol. 277, pages 26733 - 26740
	- SHINKAWA, T. ET AL., J. BIOL. CHEM., (2003), vol. 278, page 3466
	- SHIELDS, R.L. ET AL., J. BIOL. CHEM, (2001), vol. 276, pages 6591 - 6604
	- PRESTA ET AL., BIOCHEM SOC. TRANS., (2002), vol. 30, pages 487 - 490
	- LOCKHART, NATURE BIOTECHNOLOGY, (1996), vol. 14, pages 1675 - 1680
	- ASAI, ET AL., Methods in Cell Biology: Antibodies in Cell Biology, ACADEMIC PRESS, (1993), vol. 37
	- CAPECCHI ET AL., SCIENCE, (1989), vol. 244, pages 1288 - 1292
	- MORRIS GP ET AL., GASTROENTEROLOGY, (1989), vol. 96, pages 795 - 803
	- BOUGHTON-SMITH NK, BR. J. PHANNACOL., (1988), vol. 94, pages 65 - 72
	- GRISHAM MB ET AL., GASTROENTEROLOGY, (1991), vol. 101, pages 540 - 547
	- YAMADA Y ET AL., GASTROENTEROLOGY, (1992), vol. 102, pages 524 - 534
	- TORRES MI ET AL., DIG. DIS. SCI, (1999), vol. 44, pages 2523 - 29
	- NERUATH M; FUSS I; STROBER W, INT. REV. IMMUNOL., (2000), vol. 19, pages 51 - 62
	- HOFFINAN P ET AL., GUT, (1997), vol. 41, pages 195 - 202
	- JACOBSON K; MCHUGH K; COLLINS SM, GASTROENTEROLOGY, (1997), vol. 112, pages 156 - 62
	- HAMMER RE ET AL., "Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and Human b2M: An animal model of HLA-B27 associated human disorders", CELL, (1990), vol. 63, pages 1088 - 1112
	- BAUMGART DC ET AL., "Mechansisms of intestinal epithelial cell injury and colitis in interleukin 2 deficient mice", CELL IMMUNOL., (1998), vol. 187, pages 52 - 66
	- PANWALA CM ET AL., "A Novel Model of Inflammatory Bowel Disease: Mice deficient for the multiple drug resistance gene, mdrla, spontaneously develop colitis", J. IMMUNOL., (1998), vol. 161, pages 5733 - 44
	- SARTOR RB, ALIMENT. PHARMACOL. THER., (1997), pages 1189 - 96
	- SHANG-YI H. ET AL., AMER. J. INVEST. PATHOL., (2004), vol. 164, pages 747 - 756
	- UNKELESS ET AL., J. BIOL. CHEM., (1974), vol. 249, pages 4295 - 4305
	- STRICKLAND; BEERS, J. BIOL. CHEM., (1976), vol. 251, pages 5694 - 5702
	- WHUR ET AL., BR. J. CANCER, (1980), vol. 42, pages 305 - 312
	- "Angiogenesis, tumor vascularization, and potential interference with tumor growth", GULLINO, Biological Responses in Cancer, PLENUM, (1985), pages 178 - 184
	- FRESHNEY, CANCER RES., (1985), vol. 5, pages 111 - 130
	- LAZEBNIK ET AL., NATURE, (1994), vol. 371, page 346
	- HENSHALL ET AL., CANCER RESEARCH, (2003), vol. 63, pages 4196 - 4203
	- HENSHALL ET AL., ONCOGENE, (2003), vol. 22, pages 6005 - 12
	- GLYNNE ET AL., NATURE, (2000), vol. 403, pages 672 - 676
	- ZHAO ET AL., GENES DEV., (2000), vol. 14, pages 981 - 993
	- QUEEN, C. ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 10029 - 10033
	- LEVITT, M., J. MOL. BIOL., (1983), vol. 168, pages 595 - 620
	- CUISINIER ET AL., EUR. J. IMM., (1993), vol. 23, pages 110 - 118
	- RAVETCH, J.V ET AL., CELL, (1981), vol. 27, pages 583 - 591
	- MANHEIMER-LORY ET AL., J. EXP. MED., (1991), vol. 174, pages 1639 - 1652
	- STEMMER ET AL., GENE, (1995), vol. 164, pages 49 - 53
	- COLE, M.S. ET AL., J. IMMUNOL., (1997), vol. 159, pages 3613 - 3621
	- CO, M.S. ET AL., J. IMMUNOL., (1992), vol. 148, pages 1149 - 1154
	- TOVAR ET AL., IMMUNOGENETICS, (2002), vol. 54, pages 394 - 402
	- XU ET AL., CELL IMMUNOL., (2000), vol. 200, pages 16 - 26
	WO1997US01019
	WO1997US01048
	WO2000US34963

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p